Your browser doesn't support javascript.
loading
A prespecified exploratory analysis from FIDELITY examined finerenone use and kidney outcomes in patients with chronic kidney disease and type 2 diabetes.
Bakris, George L; Ruilope, Luis M; Anker, Stefan D; Filippatos, Gerasimos; Pitt, Bertram; Rossing, Peter; Fried, Linda; Roy-Chaudhury, Prabir; Sarafidis, Pantelis; Ahlers, Christiane; Brinker, Meike; Joseph, Amer; Lawatscheck, Robert; Agarwal, Rajiv.
Afiliação
  • Bakris GL; Department of Medicine, University of Chicago Medicine, Chicago, Illinois, USA. Electronic address: gbakris@uchicago.edu.
  • Ruilope LM; Cardiorenal Translational Laboratory and Hypertension Unit, Institute of Research imas12, Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBER-CV), Hospital Universitario 12 de Octubre, Madrid, Spain; Faculty of Sport Sciences, European University of Madrid
  • Anker SD; Department of Cardiology (CVK), Charité Universitätsmedizin, Berlin, Germany; Berlin Institute of Health Center for Regenerative Therapies, Charité Universitätsmedizin, Berlin, Germany; German Centre for Cardiovascular Research Partner Site Berlin, Charité Universitätsmedizin, Berlin, Germany.
  • Filippatos G; National and Kapodistrian University of Athens, School of Medicine, Department of Cardiology, Attikon University Hospital, Athens, Greece.
  • Pitt B; Department of Medicine, University of Michigan School of Medicine, Ann Arbor, Michigan, USA.
  • Rossing P; Steno Diabetes Center Copenhagen, Herlev, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Fried L; Division of Renal-Electrolyte, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Roy-Chaudhury P; Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA; WG (Bill) Hefner Salisbury VA Medical Center, Salisbury, North Carolina, USA.
  • Sarafidis P; Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Ahlers C; Statistics and Data Insights, Bayer AG, Wuppertal, Germany.
  • Brinker M; Cardiology and Nephrology Clinical Development, Bayer AG, Wuppertal, Germany.
  • Joseph A; Cardiology and Nephrology Clinical Development, Bayer AG, Berlin, Germany.
  • Lawatscheck R; Medical Affairs and Pharmacovigilance, Pharmaceuticals, Bayer AG, Berlin, Germany.
  • Agarwal R; Richard L. Roudebush VA Medical Center, Indianapolis, Indiana, USA; Indiana University, Indianapolis, Indiana, USA.
Kidney Int ; 103(1): 196-206, 2023 01.
Article em En | MEDLINE | ID: mdl-36367466
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 6_chronic_kidney_disease / 6_diabetes / 6_endocrine_disorders / 6_kidney_renal_pelvis_ureter_cancer Assunto principal: Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas / Insuficiência Renal Crônica / Falência Renal Crônica Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Kidney Int Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 6_chronic_kidney_disease / 6_diabetes / 6_endocrine_disorders / 6_kidney_renal_pelvis_ureter_cancer Assunto principal: Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas / Insuficiência Renal Crônica / Falência Renal Crônica Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Kidney Int Ano de publicação: 2023 Tipo de documento: Article